Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-02

Clinical Trial Update: To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension [Phase 1]

View source ↗

Summary

Phase 1 trial to determine blood pressure interactions between TC-5214 and anti-hypertensive medications in adults with chronic hypertension; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitors
  • Calcium channel blockers (calcium channel blocker)
  • TC-5214 (TC-5214)
  • beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Hypertension | Phase 1 | Status: TERMINATED